Over the past several decades, the incidence of neuroendocrine tumors (NETs) has sharply increased. Despite a growing patient population, the rapidly expanding field of NET research and treatment remains relatively foreign to many health care providers. NANETS thus created the regional conference program, a series of one-day events focusing on educating community health care providers on the standard management of care for NET patients, as well as new therapeutic approaches.

Our goal for these conferences is to partner with centers to further develop regional NET teams, increase patient access to clinical trials and improve the ability for NET patients to receive a comprehensive, multidisciplinary management plan. 


Accreditation & Designation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Alabama School of Medicine and the North American Neuroendocrine Tumor Society. The University of Alabama School of Medicine is accredited by the ACCME to provide continuing medical education for physicians

The University of Alabama School of Medicine designates this live activity for a maximum of  6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Location & Accommodations:  The symposium is being held at the Birmingham Marriott Hotel, 3590 Grandview Parkway, Birmingham, AL 35243.  For reservations: NANETS group rate - $115.00.

Sponsored By Statement:  Sponsored by North America Neuroendocrine Tumor Society and University of Alabama School of Medicine, Division of Continuing Medical Education.

The UAB is an affirmative action, equal opportunity institution 

The American with Disabilities Act information: Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by calling 360.314.4112.

Educational Objectives:  At the conclusion of this activity, participants will be able to:

  • Interpret current advances in the histopathology of both primary & metastatic NETs and how classification determines diagnostic approach, management and prognosis;
  • Utilize the proper assays & diagnostic techniques for identifying and monitoring NET diseases;
  • Describe the various surgical interventions for different NET sites and define the importance of incorporating an evaluation by an experienced NET surgeon into the patient’s ongoing treatment strategy;
  • Evaluate the safety and efficacy of image guided diagnostics or treatment and determine when to integrate the procedure (s) into a patient’s treatment plan;
  • Specify the risks and benefits of each liver directed therapy based on patient-specific information;
  • Identify the numerous syndromes associated with neuroendocrine tumors and define the symptoms related to each condition,
  • Compare the clinical effectiveness of the different targeted therapies and radiotherapeutic approaches to assess which intervention would be most appropriate for patients with different neuroendocrine tumors;
  • Illustrate the value of creating a  multidisciplinary team and communication system to improve the quality of care for the NET patients.

Agenda and Faculty:

Faculty Disclosure: All individuals in a position to control the content of this education activity are required to disclose all relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. 


Share this post